1. Country
2. Name of the hospital
3. Address of the hospital
4. Your name
5. Your phone number
6. Your email
7. Type of hospital
8. Does your hospital provide 24-hour admission of patients?
9. Do you have a separate chest pain unit (for less than 12 hours stay)?
10. Do you have an emergency unit (for more than 12 hours stay)?
11. Do you have a coronary care unit?
12. Number of patients with suspected acute coronary syndrome (suspected heart attack) admitted per year
13. Number of patients with final diagnosis of acute myocardial infarction (ICD codes I21-I22) per year
14. Laboratory service availability
15. Which biochemical tests do you offer for acute coronary syndrome? (you can tick more than one)
16. What is your preferred marker for diagnostic purposes? (tick only one)
17. Do you usually combine your preferred marker with other cardiac markers at your hospital?
18. If you answered yes to the previous question, select these markers from the following list.
19. Does your laboratory plan any changes regarding the biochemical markers of acute myocardial infarction in the near future? If yes, please describe.
20. Does your laboratory plan any changes regarding the decision limits of the biochemical markers in the near future? If yes, please describe.
21. Do you have a written protocol for acute coronary syndrome / use of cardiac markers?
22. If applicable, is the protocol different for emergency unit / chest pain unit?
23. Were these protocols written in collaboration with the clinicians?
24. Do you measure Troponin I? If no, go to question 38.
25. How many Troponin I test do you analyse per year?
26. Troponin I test name
27. For which clinical situation do you measure TroponinI?
28. Which sample type do you use
29. How is the test assayed?
30. If batches, how often are these run per day?
31. What is the turn-around time for routine requests (sample received in the lab to the validated result):
32. What is the turn-around time for emergency requests:
33. What is the decision limit?
34. Was the decision limit determined by...
35. The decision limits (cut-offs) were chosen by:
36. Do you have any criteria regarding frequency of testing and number of samples to be collected? If yes, please specify.
37. Do you have external quality assessment?
38. Do you measure Troponin T? If no, go to question 52.
39. How many Troponin T tests do you analyse per year?
40. Troponin T test name
41. For which clinical situation do you measure Troponin T?
42. Which sample type do you use
43. How is the test assayed?
44. If batches, how often are these run per day?
45. What is the turn-around time for routine requests (sample received in the lab to the validated result)?
46. What is the turn-around time for emergency requests?
47. What is the decision limit?
48. Was the decision limit determined by...
49. The decision limits (cut-offs) were chosen by:
50. Do you have any criteria regarding frequency of testing and number of samples to be collected? If yes, please specify.
51. Do you have external quality assessment?
52. Referring to cardiac disease, do you measure total CK? If no, go to question 67.
53. How many total CK tests do you analyse per year?
54. Assay traceability (e.g. IFCC recommended method)
55. Assay temperature
56. Total CK test name
57. Which sample type do you use
58. How is the test assayed?
59. If batches, how often are these run per day?
60. What is the turn-around time for routine requests (sample received in the lab to the validated result)?
61. What is the turn-around time for emergency requests?
62. What is the decision limit for its application in patients with acute coronary syndrome? Specify type of clinical application: diagnosis, monitoring, infarct size, etc.
63. Was the decision limit determined by...
64. The decision limits (cut-offs) were chosen by:
65. Do you have any criteria regarding frequency of testing and number of samples to be collected? If yes, please specify.
66. Do you have external quality assessment?
67. Do you measure CK-MB mass? If no, go to question 81.
68. How many CK-MB mass test do you analyse per year?
69. CK-MB mass test name
70. For which clinical situation do you measure CK-MB mass?
71. Which sample type do you use
72. How is the test assayed?
73. If batches, how often are these run per day?
74. What is the turn-around time for routine requests (sample received in the lab to the validated result)?
75. What is the turn-around time for emergency requests?
76. What is the decision limit for its application in patients with acute coronary syndrome? Specify type of clinical application: diagnosis, monitoring, infarct size, etc.
77. Was the decision limit determined by...
78. The decision limits (cut-offs) were chosen by:
79. Do you have any criteria regarding frequency of testing and number of samples to be collected? If yes, please specify.
80. Do you have external quality assessment?
81. Do you measure CK-MB activity? If no, go to question 94.
82. How many CK-MB activity tests do you analyse per year?
83. CK-MB activity test name
84. Which sample type do you use
85. How is the test assayed?
86. If batches, how often are these run per day?
87. What is the turn-around time for routine requests (sample received in the lab to the validated result)?
88. What is the turn-around time for emergency requests?
89. What is the decision limit?
90. Was the decision limit determined by...
91. The decision limits (cut-offs) were chosen by:
92. Do you have any criteria regarding frequency of testing and number of samples to be collected? If yes, please specify.
93. Do you have external quality assessment?
94. Do you measure myoglobin? If no, go to question 108.
95. How many myoglobin tests do you analyse per year?
96. Myoglobin test name
97. For which clinical situation do you measure myoglobin?
98. Which sample type do you use
99. How is the test assayed?
100. If batches, how often are these run per day?
101. What is the turn-around time for routine requests (sample received in the lab to the validated result)?
102. What is the turn-around time for emergency requests?
103. What is the decision limit for its application in patients with acute coronary syndrome? Specify type of clinical application: diagnosis, monitoring, etc.
104. Was the decision limit determined by...
105. The decision limits (cut-offs) were chosen by:
106. Do you have any criteria regarding frequency of testing and number of samples to be collected? If yes, please specify.
107. Do you have external quality assessment?
108. Number of patients with suspected heart failure admitted per year:
109. Number of patients with final diagnosis of heart failure per year:
110. Laboratory service availability:
111. Do your offer... If none go to the end.
112. For which type of population do you offer these tests?
113. Test name
114. Which sample type do you use
115. How is the test assayed?
116. If batches, how often are these run per day?
117. What is the turn-around time for routine requests (sample received in the lab to the validated result)?
118. What is the turn-around time for emergency requests?
119. What is the decision limit?
120. Was the decision limit determined by...
121. Decision limits (cut-off) chosen by:
122. Do you have any criteria regarding frequency of testing:
123. Do you have external quality assessment?
EC4 Questionnaire